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A B S T R A C T
Adipocyte fatty acid-binding protein (AFABP: FABP4) is a member of the intracellular lipid-binding protein
family that is thought to target long-chain fatty acids to nuclear receptors such as peroxisome proliferator-
activated receptor gamma (PPARγ), which in turn plays roles in insulin resistance and obesity. A molecular
understanding of AFABP function requires robust isolation of the protein in liganded and free forms as well as
characterization of its oligomerization state(s) under physiological conditions. We report development of a
protocol to optimize the production of members of this protein family in pure form, including removal of their
bound lipids by mixing with hydrophobically functionalized hydroxypropyl dextran beads and validation by
two-dimensional NMR spectroscopy. The formation of self-associated or covalently bonded protein dimers was
evaluated critically using gel ﬁltration chromatography, revealing conditions that promote or prevent formation
of disulﬁde-linked homodimers. The resulting scheme provides a solid foundation for future investigations of
AFABP interactions with key ligand and protein partners involved in lipid metabolism.
1. Introduction
Fatty acid-binding proteins (FABPs) are low molecular weight
(~15 kDa) members of the intracellular lipid-binding protein (iLBP)
family with 20–70% sequence identity [1] and the ability to bind both
long-chain fatty acids (LCFA) and other hydrophobic ligands reversibly.
Functional studies implicate FABPs in traﬃcking and targeting of
LCFAs to the nucleus, where their interactions with e.g. the peroxisome
proliferator-activated receptors (PPARs) have been demonstrated both
in vitro and for hepatocyte cells [2–5]. Some FABPs exhibit a nuclear
localization signal in their three-dimensional fold; when activated by
particular ligands, translocation of the FABP from the cytosol to the
nucleus and delivery of the ligand to its PPAR partner are promoted
[6,7]. Together these proteins play important roles in signal transduc-
tion, cell growth, cell cycle and diﬀerentiation [8]; the action of adipose
FABP, for instance, has been linked to hyperglycemia, insulin resis-
tance, and obesity [9]. In addition, some reports have correlated the
circulating level of adipocyte FABP (AFABP; FABP4) to the develop-
ment of Type-2 diabetes [9,10]. While typically considered to exist as
monomers, several FABPs appear to have a tendency to self-associate
[7,11].
To deﬁne the molecular mechanisms underlying AFABP function, it
is ﬁrst essential to isolate and characterize the protein under near-
physiological conditions. An ideal preparative method should be
eﬃcient and reproducible; it should yield an unliganded (apo) FABP
that retains its native solution-state fold and oligomerization state
without rapid deterioration; it should be amenable to probing with
respect to three-dimensional conformation and binding to ligands or
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other protein partners. These goals can be elusive even for the small
soluble iLBPs, due to the aﬃnity of FABPs for the E. coli cellular
constituents associated with their expression and/or the reported
tendency of a few family members to form dimers or multimers
[7,11,12].
This Report outlines protocols that optimize the production of
AFABP and can be extended to other members of this large protein
family. A newly developed scheme is presented to obtain eﬃcient
expression and puriﬁcation, also achieving removal of bound lipids
and/or fatty acids with validation made by two-dimensional NMR
spectroscopy. We deﬁne conditions that promote or prevent formation
of AFABP homodimers, either by self-association or covalent bonding
though disulﬁde bridges. These procedures provide a macromolecular
entity that is suitable for subsequent molecular-level studies of protein-
ligand and protein-protein interactions, both of which are involved in
metabolic signaling in mammalian tissues.
2. Materials and methods
2.1. Molecular cloning, expression, and puriﬁcation of recombinant AFABP
Scheme S1 and the accompanying commentary describe cloning of
the murine AFABP DNA including an N-terminal His6-tag and a Tobacco
Etch Virus (TEV) protease cleavage site, protein overexpression in E.
coli cells and puriﬁcation using HistidineTrap and gel ﬁltration
chromatography.
2.2. Delipidation of AFABP
Hydrophobic materials that are bound tightly to AFABP such as
endogenous lipids generated during E. coli growth were removed from
association with the protein via preferential binding to a Lipidex-5000
resin [13] (Sigma, H6383) which consisted of a lipophilic Sephadex
LH–20–100 (hydroxypropyl beaded dextran) that was substituted with
C13–C18 alkyl ethers. In our implementation of this strategy, a 5-gram
portion of dry beads was activated by immersing in 5 mL of gel
ﬁltration (GF) buﬀer (described in the Supplementary information),
then shaking in a conical Falcon tube at 37 °C for 2.5 h. To the resulting
suspension was added 40–45 mL of protein solution (50 mg of protein),
followed by shaking at 225 rpm and 37 °C for 2 h; no packed columns
were used. The beads were removed using a 0.22-μm Millipore Amicon
ﬁlter (Mahopac, NY). Two cycles of this treatment were carried out to
ensure completeness of the delipidation. Similar procedures were
followed for the intestinal and liver-type FABPs.
2.3. Isolation and development of apo-AFABP oligomers
To verify the oligomerization state of the AFABP protein, a
prepacked XK26/40 column of Superdex 75 (GE Healthcare) was used
for gel ﬁltration chromatography. Protein samples, diluted serially from
460 to 11.5 μM, were injected and eluted with GF buﬀer at a ﬂow rate
of 0.6 mL/min on XK26/40 for large loading amounts (20 mL) or
0.25 mL/min on a Superdex 75 10/300 column for small loading
amounts (100 μL). Molecular weight calibration used a protein standard
kit spanning the range of 6.5 – 75 kDa; Blue Dextran (2000 kDa) served
to determine the column void volume. Elution proﬁles were monitored
for volumes of 0–25 mL using the Absorbance at 280 nm. Relative areas
of monomer (lagging) and dimer (leading) fractions were determined in
triplicate for each sample by calculating the respective peak areas. To
test for disulﬁde linkages in the oligomers recovered from GF, standard
SDS-PAGE was compared with gels run in the presence of 25% β-
mercaptoethanol that can break such bonds.
The role of exposure to oxygen gas in the formation of putative
disulﬁde-bonded AFABP dimers was examined by monitoring the dimer
proportion as a function of time. The recovered monomer (lagging)
fraction from GF of freshly prepared AFABP was split into two portions.
One portion was treated with oxygen-free nitrogen gas, which was
passed through a reservoir containing 100 mM vanadium sulfate, 25 mL
sulfuric acid and 10 g zinc metal for one hour; the protein sample was
then sealed with a rubber cap and Paraﬁlm. The second portion was left
with the cap open to the air. Both samples were maintained at 4 °C for a
total time period of one month, including collection and testing of
aliquots by GF at roughly one-week intervals. The dimer proportion was
calculated by calculating the peak areas as a function of development
time.
2.4. Mass spectrometry
Electrospray Ionization Mass Spectrometry (ESI-MS) was performed
on a Bruker Maxis II ETD instrument (Bruker Biospin, Billerica, MA).
Samples were exchanged with 200 mM ammonium acetate by using
10 kDa Amicon Ultra-15 ﬁlters, then concentrated to 10 μM before
injection into the mass spectrometer at 3 μL/min. Typical native ESI-MS
runs used a source temperature of 150 °C, dry nitrogen gas kept at 4 L/
min, and a collision cell voltage optimized to 5 V. Matrix-assisted laser
desorption/ionization time-of-ﬂight mass spectrometry (MALDI-TOF)
was conducted with a Bruker Autoﬂex Speed-High-Performance System
using protein samples concentrated to 10 μM and mixed at 1:1 (v/v)
with 10 mg/mL of a sinapic acid matrix.
2.5. Solution-state NMR spectroscopy
The two- and three-dimensional NMR experiments [14] were
performed at 20 °C on a Bruker Avance I spectrometer operating at
500 MHz and equipped with a 5-mm TXI cryoprobe (Bruker Biospin,
Billerica, MA). The AFABP sample (400 μM, assuming all proteins are
monomers) was prepared in a solution that contained 10% (v/v) D2O,
10 mM potassium phosphate, 150 mM potassium chloride and 0.2 g/L
sodium azide, adjusted to pH 7.4. The 2D 1H–15N heteronuclear single
quantum correlation (HSQC) spectra were acquired with respective
spectral widths of 14 ppm and 32 ppm in the 1H and 15N dimensions,
requiring 8–128 scans (0.7–11 h) in separate experiments at a range of
protein concentrations. For 2D nuclear Overhauser and total correlation
spectroscopy (1H–15N NOESY-HSQC and 1H–15N TOCSY-HSQC) experi-
ments, the typical mixing and spin-lock times were 150 ms and 70 ms,
respectively. The triple-resonance experiments (HNCO, HN(CA)CO,
HNCACB and CBCA(CO)NH) were conducted using typical acquisition
and processing parameters described previously [15,16]. The resulting
data were processed using NMRPipe software [17] and analyzed by
NMRViewJ software [18].
3. Results and discussion
3.1. Apo-AFABP puriﬁcation has been optimized and validated
Following the protocol outlined in Section 2, recombinant murine
AFABP was overexpressed in E. coli and puriﬁed to obtain ~30 mg
protein per liter of LB culture (unlabeled samples) or ~25 mg per liter
of minimal media (15N- or 15N,13C-enriched protein samples for NMR
spectroscopy). After sequential puriﬁcation by aﬃnity and size exclu-
sion chromatography, TEV protease cleavage conducted with expedited
removal of the linker yielded a protein of the expected 15 kDa molar
mass that was veriﬁed to have excellent purity by both SDS-PAGE and
MALDI-TOF MS methods (Fig. 1). As compared with prior puriﬁcations
of FABPs [16,19], this method required half the time of schemes using
size exclusion and ion exchange chromatography while maintaining a
robust overall yield of ≥25 mg for a 1-L culture.
Prior publications on related members of the FABP family, including
several reports from our own laboratories, have described the removal
of bound lipids by column chromatography with Lipidex-1000 beads
(hydroxyalkoxypropyl Sephadex), hydrophobic interaction column
chromatography (phenyl Sepharose), or acidic precipitation. Such
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protocols were designed to remove either endogenous cellular materials
in the E. coli culture or 3H-oleate added to ensure protein folding and to
monitor the puriﬁcation [15,19–22]. Some studies of AFABP ligand
binding have omitted the delipidation step from the puriﬁcation
altogether, with the premise that tightly binding ligands will displace
any residual cellular lipids [7,23].
In prior solution-state structural studies of FABPs, the two-dimensional
1H–15N HSQC NMR spectra displayed an environmentally distinct amide
resonance for each backbone polypeptide residue, except for missing
signals corresponding typically to a few prolines and the 10% ﬂexible loop
sites that underwent intermediate NH exchange on the NMR timescale
[15,24,25]. However, after Lipidex-1000 chromatography we observed
~35% more AFABP signals than anticipated. Many of the weaker
resonances appeared at chemical shifts corresponding to lipid-bound
AFABP (Fig. 2, left), indicating that the standard delipidation method
was insuﬃcient. Retention of fatty acids by ~50% of human AFABP after
diverse Lipidex treatments has also been reported using solution-state
NMR and X-ray crystallography (PDB: 2HNX) [26]. Analogous puriﬁca-
tions for the liver-type and intestinal proteins of this family with currently
available Lipidex-1000 materials also showed incomplete delipidation by
NMR (Fig. S1; S. Sarkar, personal communication).
To improve the completeness of AFABP delipidation, we developed a
scheme to optimize the chromatographic matrix and improve the contact
between protein and Lipidex materials. Lipidex-5000 beads were used to
provide a more hydrophobic resin, the beads were suspended in buﬀer in a
conical tube, and the protein solution was mixed directly at a high bead-to-
protein ratio that promoted lipid removal. After two mixing cycles we
incurred losses of ~20%. Distinct apo- and holo-AFABP resonances were
observed in the undelipidated NMR spectra rather than a single peak
located at a position corresponding to a weighted average of the two
protein populations, consistent with tight lipid binding and slow exchange
of polypeptide amide groups on the NMR timescale. Comparisons of two-
Fig. 1. Chromatographic puriﬁcation of murine adipose fatty acid-binding protein (mAFABP) monitored by SDS-PAGE and veriﬁed by MALDI-TOF MS. Left: Lane 1, protein marker
ladder, with an arrow showing the mass of AFABP; lane 2, culture before induction with L-arabinose; lanes 3 and 4, 20-h induced samples, omitting and including β-mercaptoethanol
(BME) treatment to check for disulﬁde bridges; lanes 5 and 6, lysis supernatant after sonication, omitting and including BME; lanes 7 and 8, HisTrap eluate, omitting and including BME;
lanes 9 and 10, gel ﬁltration eluate, omitting and including BME. Right: The MALDI-MS data for these (undelipidated) samples exhibit two major peaks corresponding to doubly and singly
charged molecular ions, respectively.
Fig. 2. NMR contour plots of results from 1H–15N HSQC experiments [4] conducted on 200 μM adipose fatty acid-binding protein samples at a 1H frequency of 500 MHz. Chemical shifts
are referenced according to the guidelines of Wishart et al. [28]. A comparison of the un-delipidated spectrum (left, blue) and the twice-delipidated spectrum (right, black) includes green
boxed regions to highlight diﬀerences between the unliganded [22] protein state and a mixture of holo and apo states. (For interpretation of the references to color in this ﬁgure legend,
the reader is referred to the web version of this article).
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dimensional 1H–15N HSQC NMR spectra were made for un-delipidated,
once-delipidated and twice-delipidated protein samples, where Fig. 2
shows that the holo-AFABP peak intensities (left spectrum) decreased
after one cycle of delipidation (not shown) and were nearly unobservable
after two cycles (right spectrum) (<3% estimated by comparing signals to
the noise level in one-dimensional spectral slices). Native ESI-MS was also
used to conﬁrm the presence of ~55% oleate-bound AFABP in prepara-
tions to which a twofold excess of ligand had been added to stabilize the
protein after cell lysis and the absence of the holo protein after two cycles
of swirling with Lipidex-5000. The diﬀerence of mass between 8+-
charged ions appearing at m/z 1895.7977 and 1860.4012 was used to
verify the expected molecular weight of 282 g/mol for this bound species.
Thus the suspended-bead protocol described above yielded more complete
lipid removal than column chromatography – with either hydrophobic
interaction chromatography or Lipidex-5000media. Analogous procedures
were also used successfully for liver-type and intestinal FABPs (Fig. S1).
These results provided a validated means to obtain apo-AFABP and
permitted straightforward determination of sequence-speciﬁc NMR reso-
nance assignments. Although backbone amide assignments were available
for human AFABP, which displays 92% sequence similarity with the
murine AFABP studied herein [25], fewer than 30% of the chemical shift
assignments could be transferred directly. Nonetheless, it was possible to
observe 94% of the expected backbone and side chain NH resonances and
to assign 90% of the backbone NH residues site-speciﬁcally (deposited to
the BioMagResBank under accession number 27096). Standard protocols
of double-resonance (1H–15N-NOESY-HSQC and 1H–15N-TOCSY-HSQC)
and triple-resonance experiments (HNCO, HN(CA)CO, HNCACB and
CBCA(CO)NH) were used for [U-15N]-labeled and [U-13C,15N]-labeled
proteins, respectively [27,28]. Together with augmented delipidation,
these spectroscopic assignments laid the groundwork for studies of both
molecular aﬃnity and interaction loci of the fatty acid-binding protein
with respect to physiologically important ligand and protein partners by
NMR and calorimetric methods.
3.2. AFABP monomers can be separated from a minor dimer form
Although it has been widely assumed that FABPs are present in
monomeric form, at the near-physiological concentrations used for
thermodynamic and NMR studies of their interactions with ligands and
other proteins, non-covalently associated dimers were proposed by Gillilan
et al. [7]. Such associated species would not be evident in the SDS-PAGE
gels of Fig. 1 and could conceivably be missed in the 2D HSQC NMR
spectra of Fig. 2 due to the modest molecular weight of this protein. To
establish the oligomeric state of the apo-AFABP sample, a series of protein
samples at concentrations from ~10 to ~500 μM were analyzed by gel
ﬁltration size exclusion chromatography (GF), typically after refrigerated
storage for up to 25 days. The resulting elution proﬁles, which are overlaid
in Fig. 3A, each displayed two well-separated peaks from protein species
that diﬀered in molecular size, as deduced from their respective retention
volumes. Reference to calibration standards showed that the leading and
lagging peaks correspond to approximate molar masses of 32 kDa (an
AFABP dimer) and 16 kDa (the monomer). Each proﬁle showed the
lagging peak to be predominant; integration yielded a nearly invariant
dimer proportion of 13±0.3% over this 50-fold concentration range.
Moreover, GF trials with 2:1 holo-AFABP liganded to oleate, linoleate, or
troglitazone (a member of the thiazolidinediones antidiabetic drug family)
revealed comparable monomer percentages: 99±1%, 95±5%, and
91±1%, respectively, for dilution series from 500 to 10 μM [29].
The trend in GF-based relative populations reported above would be
anomalous if non-covalent association of AFABP molecules established
a monomer-dimer equilibrium, as proposed in related protein samples
under diﬀerent experimental conditions based on crystallographic,
ﬂuorescence, and small-angle light scattering evidence [7]. In that type
of dimer, the predominant monomer proportion should indicate weak
binding aﬃnity; then as the sample is diluted, the dimer proportion
should decrease to a vanishingly small value rather than remaining
constant. Conversely, if the AFABP dimer is linked by one or more
covalent bonds, then it is possible to account for the observed constancy
of the dimer proportion as a function of overall protein concentration.
In order to test this latter proposal, the leading and lagging fractions
from the GF column were each recovered and subjected to another
round of size exclusion chromatography. In the case of a non-covalent
interaction, the leading and lagging fractions should each re-establish
the identical monomer-dimer equilibrium state that would be reﬂected
in the subsequent GF elution proﬁle. Otherwise, there should be a
greater dimer proportion observed from the recovered leading fraction
Fig. 3. Elution proﬁles for murine adipose fatty acid-binding protein obtained from size exclusion chromatography (gel ﬁltration with Superdex 75). A: Dilution series (462 μM; royal blue
to 11.5 μM; navy blue) of twice-delipidated apo-AFABP samples stored for one month at 4 °C and analyzed in triplicate, showing reproducible dimer percentages within 1% for each
sample and a nearly invariant dimer percentage (13.3± 0.3%) throughout the indicated 50-fold concentration range. B: Recovered leading fraction (green) and original 15.2± 5.6 μM
apo-protein elution shown in panel A (blue). C: Recovered lagging fraction (red) and original 231.0± 0.8 μM apo-protein from the elution shown in panel A (blue). Each trace in panels B
and C represents an average of three GF chromatograms. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article).
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and a lesser proportion from the corresponding lagging fraction,
respectively. Figs. 3B and 3C show GF proﬁles that illustrate the larger
relative amount of dimer in the recovered leading fraction compared to
the recovered lagging fraction. This trend argues strongly for an AFABP
dimer that is held together (irreversibly) by covalent bond(s). The
hypothesis of a leading GF fraction in which a stable dimer predomi-
nates was also conﬁrmed using ESI-MS (Fig. S2).
3.3. The AFABP dimer is linked by disulﬁde bond(s)
Given the common observation of disulﬁde bonds in proteins [30]
and the presence of two surface-accessible cysteine residues in AFABP
[26], we hypothesize that our dimer is covalently linked in this fashion.
This supposition was tested by monitoring the protein mass in the
presence or absence of a β-mercaptoethanol disulﬁde bond reductant.
The SDS-PAGE gels of Fig. S3 showed a dimer band that disappeared
upon treatment with a β-mercaptoethanol (BME) reductant. The
retention of the 29-kDa band in the absence of BME suggests that the
dimer is covalently bound rather than self-associated; its disappearance
in the presence of BME supports identiﬁcation of the AFABP covalent
bond as a disulﬁde linkage. Interestingly, only monomers were
observed from the initial GF conducted during puriﬁcation and in the
recovered lagging fraction samples isolated directly after GF elution,
but the dimer proportions grew to ~13% and ~16%, respectively,
during refrigerated storage for one month.
3.4. The AFABP dimer forms through an N-terminal cysteine residue
Either of the two cysteine residues within the AFABP protein is a
candidate for dimer formation via a disulﬁde bond, though the N-
terminal Cys-1 is expected to have a somewhat more surface-accessible
location than Cys-117. In order to verify the location, the recovered
AFABP monomer and dimer fractions were each examined using 2D
1H–15N HSQC NMR. The overlaid spectra of Fig. 4 reveal diﬀerences in
chemical shift for several peaks, i.e., signiﬁcant perturbations in
magnetic environment for the backbone amide groups in particular
molecular regions. Sites for which the weighted 1H and 15N perturba-
tions [31] exceeded one standard deviation beyond the mean value
(Fig. S4) were mapped onto the crystal structure of the protein (PDB:
2Q9S) [7]. Fig. 5 shows that the most perturbed region of AFABP is
located at the N-terminus, close to the location of Cys-1. These NMR
results support the formation of a disulﬁde bond through the cysteine
residue at the N-terminus of the protein sequence.
3.5. AFABP dimer formation can be blocked by excluding oxygen gas
Given that disulﬁde bond formation is an energy-requiring oxidative
process, we hypothesized that oxygen gas dissolved in the phosphate
buﬀer solution could eﬀect this chemical transformation. Formation of
inter- or intramolecular S-S bridges under oxidative stress conditions
has been established, for instance, in a protein kinase and a protein-
tyrosine phosphatase, respectively [34,35]. To test our proposal, a
month-long course of dimer development was monitored for freshly
puriﬁed apo-AFABP samples in a standard oxygen-saturated buﬀer vs. a
buﬀer infused with oxygen-scrubbed nitrogen gas. The samples were
collected at 8–10 day intervals and analyzed by GF to assess their
respective dimer proportions (Fig. 6). During the initial week of the
time course the dimer population grew commensurately in the two
samples. Subsequently, dimer growth progressed linearly in the stan-
dard buﬀer but was essentially halted in the oxygen-free buﬀer
medium. After thirty-ﬁve days, the comparative dimer proportions
were 19% (oxygen-saturated control) and 5.5% (oxygen-free). (The
estimated value after 25 days is 11%, in reasonable agreement with the
13% reported in Fig. 3.) These results support the premise that
dissolved oxygen gas is the reactant responsible for formation of the
disulﬁde bond in the AFABP dimer.
Fig. 4. 500 MHz 1H–15N HSQC NMR [32] contour plot showing overlaid spectra for the
recovered monomer (blue, 400 μM) and dimer (red, 200 μM) fractions from GF
chromatography of AFABP protein samples. Chemical shifts are referenced according to
the guidelines of Wishart et al. [33]. Highly perturbed residues are labeled in the
spectrum; a complete plot of chemical shift perturbation as a function of protein sequence
appears in Fig. S4. (For interpretation of the references to color in this ﬁgure legend, the
reader is referred to the web version of this article).
Fig. 5. Mapping of signiﬁcant chemical shift perturbations on structures depicted with
PyMOL [www.pymol.org] for the AFABP dimer with respect to the corresponding protein
monomer (PDB: 2Q9S) [7]. Backbone residues highlighted in red exhibit composite
1H–15N NMR chemical shift perturbations of at least one standard deviation beyond the
mean value observed for 131 sites of the polypeptide. The cysteine residues that could
form disulﬁde bonds are highlighted in blue. (For interpretation of the references to color
in this ﬁgure legend, the reader is referred to the web version of this article).
Fig. 6. Proportion of dimers present as a function of time for 56.3 μM (assuming all
proteins are monomers) freshly prepared AFABP samples that were stored in buﬀers
saturated with oxygen (blue curve) or infused with oxygen-scrubbed nitrogen gas (red
curve). Percentages were derived from elution proﬁles of Superdex 75 size exclusion gel
ﬁltration chromatography analogous to those illustrated in Fig. 3. Error bars denote
results from triplicate GF runs on the same sample. (For interpretation of the references to
color in this ﬁgure legend, the reader is referred to the web version of this article).
Q. Wang et al. Biochemistry and Biophysics Reports 10 (2017) 318–324
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4. Context and conclusions
Molecular structural studies at near-physiological concentrations
can oﬀer insights and generate hypotheses regarding protein function.
For AFABP, these include sequestration of hydrophobic fatty acid
metabolic products and transfer of fatty acids to protein binding
partners in the nucleus (e.g., PPARγ and JAK2) to eﬀect metabolic
signaling [8,9]. Such studies require well-deﬁned protein-ligand and
protein-protein systems of high purity, underscoring the importance of
robust production and rigorous biophysical characterization. For mem-
bers of the FABP family, it can be challenging to fulﬁll the latter
requirement in light of tight ligand binding and possible dimerization.
We have developed an eﬃcient puriﬁcation scheme that provides
≥20 mg of 15N-labeled protein from a liter of bacterial culture in
minimal media, matching average yields of 15 mg (LFABP) and 25 mg
(IFABP) in rich media with traditional FABP isolation procedures while
achieving time savings of a factor of two [2,15,16]. This protocol
includes robust delipidation that removes> 97% of fatty acids that can
have reported Kd values as low as 10 nM [36], keeps losses to a
manageable 20% after two removal cycles, avoids the use of radioactive
tracers, and can be cross-validated by solution-state NMR.
In contrast to a prior proposal of dimer-driven AFABP activation of
nuclear localization that eﬀects metabolic regulation associated with
the PPARγ receptor [7], the current measurements did not reveal self-
association of AFABP in the manner mentioned in these reports. These
divergent results are likely to reﬂect both crystal packing eﬀects that
can produce dimers and diﬀerences in respective sample history. For
instance, retention of an N-terminal His-tag by Gillilan, et al. could
preclude disulﬁde bond formation at Cys-1 while permitting the dimer
formation evidenced in ﬂuorescence titrations and small-angle X-ray
scattering experiments. The possible retention of endogenous lipids in
these and other published studies could also impact both protein
interactions with hydrophobic ligands and associated conformational
changes.
Nonetheless, oligomerization state is a potentially important con-
sideration with respect to AFABP activation, making it essential to
recognize and control the formation of aggregates, including both non-
covalently associated and disulﬁde-linked dimers. Dimers of the type
observed herein could also be formed by other FABPs for which the Cys-
1 residue is conserved; examples include bacterial, fruit ﬂy, poultry,
and ﬁsh homologs but no other mammalian FABPs [37–40]. S-S
linkages in this protein family have been reported in two instances:
for rat cutaneous FABP (FABP5), which has six cysteine residues and
forms an intramolecular disulﬁde linkage (but no dimers), putatively by
a red-ox mechanism [41]; and for human heart FABP (FABP3), where
dimerization secondary to an intermolecular S-S bond was found [11].
Given the proposed involvement of helix-loop-helix residues in ligand
binding and nuclear localization of these proteins [7], dimer formation
through the N-termini could conceivably occur without impacting the
aﬃnity of FABPs for ligands or nuclear receptors. To avoid the
unwitting formation of disulﬁde-linked protein dimers in AFABP
solutions, a protocol of buﬀer degassing during the puriﬁcation steps,
exclusion of oxygen, and/or addition of reducing agents such as TCEP is
recommended. The protocols reported herein lay the groundwork for
future investigation of the conformational basis of AFABP interactions
with contrasting ligands and proteins such as PPARγ, RAR, and JAK2
that are involved in lipid signaling.
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